Literature DB >> 12005431

The structural basis of localization and signaling by the focal adhesion targeting domain.

Stefan T Arold1, Maria K Hoellerer, Martin E M Noble.   

Abstract

The localization of focal adhesion kinase (FAK) to sites of integrin clustering initiates downstream signaling. The C-terminal focal adhesion targeting (FAT) domain causes this localization by interacting with talin and paxillin. FAT also mediates signaling through Grb2 via phosphorylated Y925. We report two crystal structures of the FAT domain. Large rearrangements of the structure are indicated to allow phosphorylation of Y925 and subsequent interaction with Grb2. Sequence homology and structural compatibility suggest a FAT-like fold for the C-terminal domains of CAS, Efs/Sin, and HEF1. A structure-based alignment including these proteins and the vinculin tail domain reveals a conserved region that could play a role in focal adhesion targeting. Previously postulated "paxillin binding subdomains" may contribute to structural integrity rather than directly to paxillin binding.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12005431     DOI: 10.1016/s0969-2126(02)00717-7

Source DB:  PubMed          Journal:  Structure        ISSN: 0969-2126            Impact factor:   5.006


  69 in total

1.  Conformational dynamics of the focal adhesion targeting domain control specific functions of focal adhesion kinase in cells.

Authors:  Gress Kadaré; Nicolas Gervasi; Karen Brami-Cherrier; Heike Blockus; Said El Messari; Stefan T Arold; Jean-Antoine Girault
Journal:  J Biol Chem       Date:  2014-11-12       Impact factor: 5.157

2.  Structural and functional characterization of the VirB5 protein from the type IV secretion system encoded by the conjugative plasmid pKM101.

Authors:  Hye-Jeong Yeo; Qing Yuan; Moriah R Beck; Christian Baron; Gabriel Waksman
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-12       Impact factor: 11.205

3.  FERM domain interaction promotes FAK signaling.

Authors:  Jill M Dunty; Veronica Gabarra-Niecko; Michelle L King; Derek F J Ceccarelli; Michael J Eck; Michael D Schaller
Journal:  Mol Cell Biol       Date:  2004-06       Impact factor: 4.272

4.  Integrative Copy Number Analysis of Uveal Melanoma Reveals Novel Candidate Genes Involved in Tumorigenesis Including a Tumor Suppressor Role for PHF10/BAF45a.

Authors:  Hima Anbunathan; Ruth Verstraten; Arun D Singh; J William Harbour; Anne M Bowcock
Journal:  Clin Cancer Res       Date:  2019-06-21       Impact factor: 12.531

5.  A FAK/Src chimera with gain-of-function properties promotes formation of large peripheral adhesions associated with dynamic actin assembly.

Authors:  Priscila M F Siesser; Leslie M Meenderink; Larisa Ryzhova; Kristin E Michael; David W Dumbauld; Andrés J García; Irina Kaverina; Steven K Hanks
Journal:  Cell Motil Cytoskeleton       Date:  2008-01

Review 6.  Structure and mechanics of integrin-based cell adhesion.

Authors:  M Amin Arnaout; Simon L Goodman; Jian-Ping Xiong
Journal:  Curr Opin Cell Biol       Date:  2007-10-24       Impact factor: 8.382

7.  In vitro phosphorylation of the focal adhesion targeting domain of focal adhesion kinase by Src kinase.

Authors:  Jennifer Cable; Kirk Prutzman; Harsha P Gunawardena; Michael D Schaller; Xian Chen; Sharon L Campbell
Journal:  Biochemistry       Date:  2012-03-08       Impact factor: 3.162

8.  Dynamics and mechanism of p130Cas localization to focal adhesions.

Authors:  Dominique M Donato; Larisa M Ryzhova; Leslie M Meenderink; Irina Kaverina; Steven K Hanks
Journal:  J Biol Chem       Date:  2010-04-29       Impact factor: 5.157

9.  Structural basis for the autoinhibition of focal adhesion kinase.

Authors:  Daniel Lietha; Xinming Cai; Derek F J Ceccarelli; Yiqun Li; Michael D Schaller; Michael J Eck
Journal:  Cell       Date:  2007-06-15       Impact factor: 41.582

10.  Structural similarity-based predictions of protein interactions between HIV-1 and Homo sapiens.

Authors:  Janet M Doolittle; Shawn M Gomez
Journal:  Virol J       Date:  2010-04-28       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.